Robert Thomas Manguso, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 2 | 2023 | 51 | 1.500 |
Why?
|
| Immunotherapy | 8 | 2023 | 4445 | 0.950 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2023 | 91 | 0.920 |
Why?
|
| Killer Cells, Natural | 4 | 2023 | 2133 | 0.740 |
Why?
|
| Melanoma, Experimental | 3 | 2019 | 561 | 0.730 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2023 | 4479 | 0.730 |
Why?
|
| Tumor Escape | 3 | 2018 | 349 | 0.640 |
Why?
|
| Lentivirus | 1 | 2021 | 501 | 0.620 |
Why?
|
| Dinoprostone | 1 | 2020 | 600 | 0.620 |
Why?
|
| Neoplasms | 7 | 2023 | 21683 | 0.440 |
Why?
|
| Genetic Vectors | 1 | 2021 | 3420 | 0.390 |
Why?
|
| Immune Evasion | 3 | 2023 | 360 | 0.380 |
Why?
|
| Tumor Microenvironment | 7 | 2023 | 3586 | 0.350 |
Why?
|
| Histocompatibility Antigens Class I | 5 | 2022 | 1366 | 0.350 |
Why?
|
| Interferons | 3 | 2023 | 706 | 0.320 |
Why?
|
| Genetic Testing | 1 | 2021 | 3444 | 0.310 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2021 | 3143 | 0.260 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 4262 | 0.240 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2023 | 5172 | 0.230 |
Why?
|
| Antigen Presentation | 2 | 2021 | 1284 | 0.230 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily C | 1 | 2022 | 32 | 0.220 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 222 | 0.210 |
Why?
|
| Burkitt Lymphoma | 1 | 2023 | 327 | 0.200 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2022 | 162 | 0.190 |
Why?
|
| DNA Mismatch Repair | 1 | 2023 | 426 | 0.180 |
Why?
|
| Dioxygenases | 1 | 2022 | 316 | 0.180 |
Why?
|
| Interferon-gamma | 3 | 2023 | 3206 | 0.180 |
Why?
|
| Mice | 14 | 2023 | 81183 | 0.170 |
Why?
|
| Antibodies, Blocking | 1 | 2019 | 253 | 0.160 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 849 | 0.150 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2022 | 1369 | 0.150 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 670 | 0.140 |
Why?
|
| Adenosine Deaminase | 1 | 2018 | 241 | 0.140 |
Why?
|
| Bile Duct Neoplasms | 1 | 2022 | 567 | 0.140 |
Why?
|
| Cholangiocarcinoma | 1 | 2022 | 516 | 0.140 |
Why?
|
| Leukemia | 1 | 2023 | 1511 | 0.130 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 233 | 0.130 |
Why?
|
| Animals | 16 | 2023 | 168757 | 0.130 |
Why?
|
| Genetic Engineering | 1 | 2021 | 951 | 0.130 |
Why?
|
| Gene Silencing | 1 | 2021 | 1538 | 0.120 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1038 | 0.110 |
Why?
|
| Headache | 1 | 2020 | 1226 | 0.110 |
Why?
|
| Autophagy | 1 | 2021 | 1300 | 0.110 |
Why?
|
| Disease Models, Animal | 4 | 2023 | 18029 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 21827 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 6386 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 1634 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 1903 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 2727 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3557 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2017 | 2499 | 0.080 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 2734 | 0.080 |
Why?
|
| Software | 1 | 2022 | 4443 | 0.080 |
Why?
|
| Phenotype | 2 | 2020 | 16365 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2021 | 19229 | 0.060 |
Why?
|
| Humans | 15 | 2023 | 744343 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2023 | 10180 | 0.060 |
Why?
|
| Tumor Necrosis Factors | 1 | 2023 | 109 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 5256 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 182 | 0.050 |
Why?
|
| Genome | 2 | 2023 | 1808 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 244 | 0.050 |
Why?
|
| Genomics | 1 | 2017 | 5720 | 0.050 |
Why?
|
| Inositol | 1 | 2022 | 218 | 0.050 |
Why?
|
| Spheroids, Cellular | 1 | 2023 | 351 | 0.050 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2022 | 295 | 0.050 |
Why?
|
| Gene Library | 1 | 2023 | 1074 | 0.040 |
Why?
|
| Caspases | 1 | 2023 | 928 | 0.040 |
Why?
|
| Mice, Congenic | 1 | 2019 | 99 | 0.040 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2019 | 132 | 0.040 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2019 | 168 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 2019 | 315 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 890 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 16689 | 0.040 |
Why?
|
| RNA Editing | 1 | 2018 | 148 | 0.040 |
Why?
|
| DNA Transposable Elements | 1 | 2021 | 748 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2018 | 290 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2021 | 1035 | 0.040 |
Why?
|
| Organoids | 1 | 2023 | 701 | 0.040 |
Why?
|
| Genes, Essential | 1 | 2018 | 183 | 0.040 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2022 | 871 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2022 | 1381 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 1276 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 1270 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2022 | 1783 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 1821 | 0.030 |
Why?
|
| Collagen | 1 | 2022 | 2689 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 6314 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1222 | 0.020 |
Why?
|
| DNA | 1 | 2023 | 7301 | 0.020 |
Why?
|
| Chromatin | 1 | 2021 | 2934 | 0.020 |
Why?
|
| Cell Line | 1 | 2023 | 15997 | 0.020 |
Why?
|
| Cytokines | 1 | 2022 | 7322 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 5524 | 0.020 |
Why?
|
| Mutation | 2 | 2022 | 29786 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10481 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 9648 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2022 | 11483 | 0.020 |
Why?
|
| Female | 4 | 2022 | 380194 | 0.010 |
Why?
|
| Inflammation | 1 | 2018 | 10638 | 0.010 |
Why?
|
| Melanoma | 1 | 2017 | 5510 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6773 | 0.010 |
Why?
|
| Male | 1 | 2022 | 350118 | 0.000 |
Why?
|